NHS Greater Glasgow and Clyde is one of the largest healthcare systems in the UK employing around 40,000 staff in a wide range of clinical and non-clinical professions and job roles. We deliver acute hospital, primary, community and mental health care services to a population of over 1.15 million and a wider population of 2.2 million when our regional and national services are included.
The Beatson West of Scotland Cancer Centre (WoSCC) is seeking to appoint a Consultant Clinical Oncologist with a special interest in Paediatric Radiotherapy and Head and Neck Cancers.
The Beatson West of Scotland Cancer Centre (BWoSCC) is Scotland’s largest cancer centre and the second largest in the UK. The centre has undergone unprecedented investment and our clinical teams deliver oncology services to a catchment population of 2.9 million people across 4 Health Board areas. The centre is part of the CRUK virtual comprehensive cancer treatment and research centre which also includes the Beatson Institute for Cancer Research and the soon to be built Translational Research Centre.
The equipment in the centre is state-of-the-art, including 11 linear accelerators with on-board imaging, and incorporates Image Guided Radiotherapy (IGRT), IMRT, and Stereotactic Radiotherapy into our portfolio of available technologies. The centre uses VMAT technology to more effectively deliver IMRT. A completely new brachytherapy unit and programme has been established in the centre. A state-of-the-art satellite centre opened on the Monklands hospital site in Lanarkshire in November 2015 to specifically address radiotherapy capacity issues.
The Beatson is an internationally renowned academic centre, with Professors of Medical Oncology, Clinical Oncology, Translational Research, and Palliative Care currently in post.
The Beatson West of Scotland Cancer Centre Clinical research unit is the largest of its kind funded by Cancer Research UK. The unit offers support to all clinicians within the BWoSCC to initiate and conduct first-in-man clinical trials. The unit has a large portfolio of Phase I-III studies across the range of cancer sub-specialties and has a particular interest in the development of new anti-cancer drugs, supported by designated staff and facilities for Phase I/early Phase II clinical trials.
Applicants should have full GMC registration and/or eligibility to be included on the Specialist Register. UK trainees will have evidence of Higher Specialist Training leading to CCT, or be within six months of confirmed entry from the date of interview. Non-UK applicants must demonstrate equivalent training.
For further details of the posts, please contact: The Clinical Director, Dr. Ioanna Nixon +44 (0)141 301 7088, e-mail
Ioanna.nixon@nhs.scot .
Interview Date: 12/02/2025
NHS Greater Glasgow and Clyde encourages applications from all sections of the community. We promote a culture of inclusion across the organisation and are proud of the diverse workforce we have.
To apply, please click the Apply Button.
#J-18808-Ljbffr